Prolepsia forecastYes / no

Will the European Commission open more than 10 Phase 2 merger investigations in 2027?

As of 16 November 2026, Prolepsia puts the chance of yes at 3%.

3%chance of yes

Yes 3%No 97%
Prolepsia forecast made

How Prolepsia reasons

The report Prolepsia wrote with this forecast.

How forecasts are made · Track record

TL;DR

The forecast is 3.4% Yes and 96.6% No. The Commission is strongly favored to remain at 10 or fewer qualifying openings in 2027; reaching at least 11 would require a substantial reversal of recent practice.

Key evidence

  • The recent baseline is low. The Commission recorded five Phase II openings in 2023, three in 2024 and four in 2025. Only two of the 16 complete years from 2010 through 2025 exceeded 10, and the last was 2018 (official statistics).
  • Merger activity has not collapsed. Notifications totaled 392 in 2024 and 384 in 2025. The provisional January–October 2026 figures show 330 notifications but only three Phase II openings. This points toward low escalation, not simply a shortage of filings (Commission statistics).
  • Competition concerns need not lead to Phase II. All nine conditional clearances in 2025 involved remedies offered during Phase I. Negotiated fixes can therefore absorb difficult transactions without adding qualifying investigations (2025 Competition Report).
  • The policy signal is mixed. Draft merger guidelines expand analysis of innovation and other competitive harms, while also recognizing beneficial scale, efficiencies and innovation protections. They do not establish a numerical opening target (technical summary).

Uncertainties

The largest risk is that several difficult transactions enter formal review together and trigger Phase II during 2027. KONE/TK Elevator, Uber/Delivery Hero and Project Bromo provide concrete reasons to watch the pipeline, but their timing, remedies and procedural paths remain unresolved. Further transactions can also emerge.

The partial-year 2026 count is provisional because the available statistical versions differ. Final guideline adoption and its effect on initiation practice were also unverified as of the forecast date.

The calendar boundary matters: only formal initiation decisions adopted in 2027 count. Investigations opened earlier, Phase I remedies and national proceedings do not. The Commission’s search guide distinguishes initiation decisions from final Phase II decisions (case-search guide).

Read the full report

TL;DR

The forecast is 3.4% Yes and 96.6% No. Plan around the Commission opening 10 or fewer qualifying Phase II merger investigations in 2027. The decisive evidence is the recent low opening rate, while the principal risk is a concentrated wave of difficult transactions and a shift in escalation practice.

Context

This question measures formal starts, not the stock of investigations or the number of final decisions. A qualifying case must receive its formal initiation decision during the 2027 calendar year. Exactly 10 resolves No; at least 11 resolves Yes. The Commission’s case-search guide distinguishes Article 6(1)(c) initiation decisions from final Phase II decisions, a distinction that is essential to counting the right events (case-search guide).

As of November 16, 2026, the evidence points to a subdued opening rate despite continued merger activity. The Commission is also reviewing its merger-assessment guidelines, with completion targeted for Q4 2026. Final adoption was not verified by the forecast date, and the proposed changes do not point uniformly toward more investigations (guidelines review).

Evidence

The historical backbone is straightforward: crossing this threshold has happened, but not often, and not recently. The complete annual history available for 2004–2025 is below. These are Phase II initiation counts, not completed investigations, from the Commission’s current statistical series (official merger statistics).

Year Phase II openings
2004 8
2005 10
2006 13
2007 15
2008 10
2009 5
2010 4
2011 8
2012 10
2013 6
2014 8
2015 11
2016 8
2017 7
2018 12
2019 8
2020 8
2021 7
2022 8
2023 5
2024 3
2025 4

Four of these 22 complete years exceeded 10. Within the more recent 2010–2025 period, only two of 16 did so. The last crossing was in 2018. The latest three complete years show a lower level than the preceding period, rather than one isolated weak year (official merger statistics). I read this as evidence that older high-count years should inform the risk of a rebound, not define the current baseline.

The available 2026 evidence continues that pattern. The newer statistical text reports three openings through October 31, 2026. An older June version reports one opening through June 30. These are partial-year observations with different cutoffs, and the mismatch between available versions makes the newer count provisional (Commission statistics). Neither observation establishes the final annual total.

The notification figures help distinguish weak merger activity from low escalation. The available history is 392 notifications in 2024, 384 in 2025, 191 through June 2026 in the older statistical version, and 330 through October 2026 in the newer version. The two 2026 observations overlap and must not be added together (official merger statistics). These figures do not show a collapse in filings comparable to the low number of Phase II openings. Transaction mix and the route used to resolve concerns matter more than headline deal volume alone.

There is direct evidence for one such route. The Commission’s 2025 report confirms four Phase II openings and says all nine conditional clearances involved remedies offered during Phase I. It also reports that 88% of decisions used the simplified procedure (2025 Competition Report). The inference is not that competition concerns disappeared. It is that concerns can be addressed without a qualifying opening.

That mechanism remained visible in 2026. The Commission’s selected intervention list includes six Phase I commitments clearances: Carlyle/BASF Coatings, Holcim/Xella, Baker Hughes/Chart, Paramount/Warner, Kimberly-Clark/Kenvue and AkzoNobel/Axalta. This is not a complete denominator for calculating a clearance rate, but it demonstrates that substantial transactions can take the remedy route before Phase II (intervention overview).

The prospective pipeline supplies the strongest evidence against a quiet year. KONE said on October 28 that its TK Elevator transaction remained in Commission pre-notification (earnings-call transcript). Reported plans for European disposals show both sides of the risk: the deal raises substantive competition questions, but advance remedies could prevent a Phase II opening (reported disposal plans). Pre-notification also leaves the eventual opening year unresolved.

Uber/Delivery Hero presents a different issue. Uber’s announced structure separates businesses in 14 markets into an SSW transaction (transaction announcement). Reporting describes a complaint about SSW’s independence, financing and possible coordinated effects, alongside party-side denials of Uber governance rights. A possible separate referral creates additional procedural uncertainty, not an assured additional investigation (complaint reporting). Delivery Hero targets completion in H2 2027, but a completion target does not establish an initiation date (trading update).

Project Bromo also provides a concrete pipeline signal. An employee-representative account anticipated signing at the end of 2026 and competition approvals in H1 2027. That supports an active transaction process, but it is not a Commission procedural record. Filing timing, later schedule changes and possible advance remedies remain unresolved (employee-representative account).

Jurisdiction limits the usefulness of a broad European deal watchlist. The French competition authority said it would review the linked SFR transactions. Those reviews do not contribute to the Commission’s count unless jurisdiction changes and the Commission itself opens Phase II (French authority statement).

Policy and legal developments add upward risk without establishing its size. The draft guidelines expand discussion of innovation, entrenchment, foreclosure and portfolio effects, but also recognize procompetitive scale, dynamic efficiencies and an innovation shield (technical summary). The Booking/Etraveli judgment supports scrutiny of ecosystem effects (Court summary). National call-in powers can also expand the pool of transactions considered for referral, but a national call-in, a Commission referral and a Commission Phase II opening are separate steps (ECN statement).

What's non-obvious

The easy mistake is to equate more aggressive competition analysis with more qualifying investigations. This question counts a procedural gateway. Strong scrutiny can produce advance disposals, Phase I commitments, withdrawal or national review instead. A difficult merger is not automatically a Phase II opening. The evidence on early remedies is therefore central, not a side issue.

Timing is another source of overcounting. A prominent deal targeting completion in 2027 can enter Phase II before the year starts, clear without Phase II, or slip beyond the year. Likewise, an investigation already open can dominate 2027 headlines without adding anything to the count. The relevant signal is a cluster of distinct formal initiation decisions inside the calendar window—not a cluster of prominent merger stories.

Uncertainties

The main substantive uncertainty is a change in transaction mix or escalation practice. Several difficult cases arriving together could overcome the recent low baseline. The pipeline is not fixed, and additional transactions can emerge before or during 2027. Conversely, the identified candidates can leave the pipeline through remedies, withdrawal, jurisdictional decisions or timing shifts.

The policy effect remains unresolved. Final guideline adoption was not verified at the cutoff, and the proposals contain provisions that work in both directions. Broader harm theories can increase scrutiny; stronger efficiency arguments can facilitate clearance or require more investigation before acceptance. There is no established numerical effect on annual openings.

The remaining data gap is a complete decision-level census of current openings and their adoption dates. The provisional 2026 aggregate and conflicting statistical vintages limit precision, but do not establish that unobserved cases are absent. A reconciled official series, the final guidelines and formal procedural records for the major pipeline deals would narrow the uncertainty. Resolution should ultimately follow individual initiation decisions in the Commission’s official case records, rather than press-release dates or aggregate summaries (Competition Case Search).

Forecast history

How Prolepsia’s forecast has movedOne forecast so far: 3% on 16 Nov 2026.
DateForecast
3% chance of yes

Sources Prolepsia read

  1. cases search user guide - Competition Policy - European Commissioncompetition-policy.ec.europa.eu
  2. Q3 2026 KONE Oyj Earnings Call on October 28, 2026 / 8:30AMassets.kone.com
  3. reported disposal planslive.euronext.com
  4. Uber Technologies, Inc. - Uber Announces Acquisition Offer for Delivery Heroinvestor.uber.com
  5. Uber’s Delivery Hero deal prompts early complaint to the EC - ION Analyticsionanalytics.com
  6. trading updateir.deliveryhero.com
  7. 17/07/2026: BROMO – Les « ESSENTIELS » de la 4ème réunion d’information (3ème réunion de la procédure sociale) - UNSA AIRBUSairbus.unsa.org
  8. Télécoms – SFR : l’Autorité de la concurrence sera l’autorité en charge de l’examen du rachat de SFR (Altice France) | Autorité de la concurrencewww.autoritedelaconcurrence.fr
  9. Competition Case Searchcompetition-cases.ec.europa.eu
  10. Initiation of proceedings (Case M.12270 – UPM-KYMMENE / SAPPI / JV)eur-lex.europa.eu

The question

This question asks whether the European Commission will formally initiate more than 10 Phase II (in-depth) merger investigations during the 2027 calendar year, from January 1, 2027, through December 31, 2027, inclusive. Under the EU Merger Regulation (Council Regulation (EC) No 139/2004), the European Commission reviews mergers and acquisitions that fall within its jurisdiction. Following an initial Phase I review, the Commission may initiate a Phase II investigation when a proposed transaction raises serious doubts about its compatibility with the internal market. Phase II investigations involve a more detailed assessment of potential competition concerns and ordinarily provide the Commission with 90 working days to reach a decision, subject to extensions and suspensions. Historically, Phase II investigations have represented a small minority of merger reviews. According to the European Commission's official competition reports, the Commission opened three Phase II merger investigations in 2024 and four in 2025. These figures provide context for the question's threshold of more than 10 investigations, which would represent a substantial increase relative to these recent years. As of November 16, 2026, the European Commission is also undertaking a review of its merger assessment guidelines, potentially affecting its approach to merger control in subsequent years. The forecast concerns the number of distinct merger cases in which the Commission formally opens Phase II proceedings during 2027, regardless of when the underlying transaction was notified or when the investigation concludes. Sources: European Commission, Competition Policy merger procedures (https://competition-policy.ec.europa.eu/mergers/procedures_en); European Commission, Competition Case Search user guide (https://competition-policy.ec.europa.eu/mergers/practical-information/cases-search-user-guide_en); European Commission, 2025 Competition Report (https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:52026SC0125); European Commission, Review of the Merger Guidelines (https://competition-policy.ec.europa.eu/mergers/review-merger-guidelines_en).

How it resolves

The question resolves YES if the European Commission formally initiates Phase II merger investigations in at least 11 distinct merger cases between January 1, 2027, and December 31, 2027, inclusive. It resolves NO if the Commission initiates Phase II investigations in 10 or fewer distinct merger cases during that period. An investigation counts when the European Commission adopts a formal decision initiating proceedings under Article 6(1)(c) of Council Regulation (EC) No 139/2004, or an equivalent successor provision if the relevant legislation changes during 2027. The controlling date is the date on which the Commission adopts the formal initiation decision, not the date of a press release, publication in the Official Journal, notification of the merger, or final decision. The primary resolution source will be the European Commission's official Competition Case Search database (https://competition-cases.ec.europa.eu/search), using merger cases classified under the decision type 'Art 6.1 (c): initiation of proceedings (start of phase II).' The Commission's official merger statistics, annual competition reports, press releases, and notices of initiation published in the Official Journal of the European Union will serve as supplementary sources for verification. Each distinct merger case will be counted once, identified by its official Commission merger case number, even if multiple procedural decisions or announcements concern the same investigation. Investigations opened before January 1, 2027, will not count, even if they remain ongoing during 2027. Investigations formally opened during 2027 will count even if they are subsequently withdrawn, terminated, cleared, prohibited, or otherwise concluded. Investigations initiated by national competition authorities of EU member states will not count unless the European Commission itself formally initiates Phase II proceedings in the relevant merger case. Resolution should take place after December 31, 2027, once the Commission's official records are sufficiently complete to establish the total. If official records disagree, the individual formal initiation decisions and their adoption dates will take precedence over aggregate statistical summaries. If the threshold of 11 qualifying investigations is definitively reached during 2027, the question may resolve YES immediately. Otherwise, the final count should be established after the calendar year ends, allowing until March 31, 2028, for delayed publications or corrections. If the Commission's records remain incomplete or unavailable by that date and the outcome cannot be established reliably from other official EU documentation, the question will be annulled rather than assigned an unsupported YES or NO outcome.

Fine print

The threshold is strictly greater than 10: exactly 10 qualifying investigations resolves NO, while 11 or more resolves YES. The relevant period follows calendar dates in Brussels, Belgium, where the European Commission is headquartered. Phase I investigations, Phase I clearance decisions with commitments, preliminary inquiries, market investigations, antitrust proceedings, Digital Markets Act investigations, and in-depth investigations under the EU Foreign Subsidies Regulation are excluded. Only Phase II merger investigations formally initiated by the European Commission count. Merger investigations involving companies headquartered outside the European Union are included if they fall within the Commission's merger-control jurisdiction. Cases referred to the Commission from national competition authorities are included if the Commission formally initiates Phase II proceedings during 2027. If multiple transactions are reviewed under a single Commission merger case number and a single Phase II initiation decision, they count as one investigation. If distinct merger case numbers correspond to separate formal Phase II initiation decisions, they count separately. Reopenings, procedural extensions, or suspensions of existing Phase II investigations do not count as new openings unless they involve a genuinely new, distinct formal initiation of Phase II proceedings in a separate merger case. If EU merger-control legislation is amended or replaced during 2027, proceedings under a successor framework will count only if they are substantively equivalent to the current Phase II merger-review procedure. If the Commission temporarily or permanently loses its authority to open such proceedings, the question will still resolve based on the number of qualifying investigations actually opened during 2027, rather than being automatically annulled.